Jeff Blackard

Jeff Blackard serves as a Contracting Specialist within the National CMOP Office of the Department of Veterans Affairs, where he plays a pivotal role in securing the domestic production and distribution of mission-critical pharmaceuticals, diagnostic substances, and medical consumables. His procurement activities are central to maintaining the nation’s sovereign manufacturing capability for essential veteran healthcare supplies, ensuring supply chain resilience against foreign dependencies. Blackard routinely manages complex acquisitions under FAR Part 13 and Part 15, focusing on manufacturing contracts, technical services, and specialized logistics support to sustain operational readiness across VA medical facilities. He maintains consistent working relationships with a core group of specialized contractors, including All In Solutions LLC, Ansible Government Solutions LLC, and Innovation Associates, Inc., who provide expertise in pharmaceutical formulation, sterile compounding, and regulated manufacturing compliance. His contracting patterns reflect long-term vendor partnerships grounded in quality assurance, cGMP adherence, and supply chain traceability, with a preference for firms possessing proven experience in federal pharmaceutical production and FDA-regulated environments. Blackard’s procurement strategy prioritizes open competition, with 94% of awards issued without set-asides, reflecting the technical specificity and scale of required manufacturing capabilities. However, he actively supports small business participation through the 6% allocated to Total Small Business Set-Asides under FAR 19.5, ensuring qualified small manufacturers have access to opportunities within the CMOP’s mission-critical supply chain. His primary industry focus lies in NAICS 325412 (Pharmaceutical Preparation Manufacturing), followed by 325413 (In-Vitro Diagnostic Substance Manufacturing), indicating deep expertise in sterile drug production, radiopharmaceuticals, and diagnostic reagents. He also procures related components such as industrial valves and specialized chemical materials, demonstrating technical fluency across the end-to-end pharmaceutical supply ecosystem.